Yuyu Pharma, Inc. (KRX:000220)

Yuyu Pharma Revenue

Yuyu Pharma had revenue of 36.70B KRW in the quarter ending June 30, 2026, with 2.37% growth. This brings the company's total for the last twelve months to 144.37B, up 6.69% year-over-year. In the year 2025, Yuyu Pharma had annual revenue of 140.88B with 5.81% growth. That makes Yuyu Pharma the 22,099th largest company in the world by revenue and 1,223rd in South Korea.

• Revenue (ttm): 144.37B
• Revenue Growth: +6.69%
• P/S Ratio: 0.40
• Revenue / Employee: 594.12M
• Employees: 243
• Market Cap: 58.11B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Yuyu Pharmaceutical 96.72B 68.5%
• Yuyu Healthcare 38.28B 27.1%
• Yuyu Medicals 6.12B 4.3%

By Geography

Chart

• South Korea 139.85B 99.3%
• Overseas 1.03B 0.7%

Fiscal year ended Dec 31, 2025 See the full Yuyu Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	140.88B	7.74B	5.81%
Dec 31, 2024	133.15B	-4.06B	-2.96%
Dec 31, 2023	137.21B	-1.67B	-1.20%
Dec 31, 2022	138.88B	23.23B	20.08%
Dec 31, 2021	115.66B	17.54B	17.87%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error